South San Francisco, California

and

Vancouver, Canada

,

March 10, 2022

/PRNewswire/ – ESSA Pharma Inc. (“ESSA”, or the “Company”) (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be presenting at the virtual Oppenheimer 32

^nd

Annual Healthcare Conference on

Thursday, March 17, 2022

at

2:40 p.m. Eastern Time

.

David. R. Parkinson, President and Chief Executive Officer of ESSA Pharma, will participate in and host one-on-one meetings.

Peter Virsik

, ESSA’s Chief Operating Officer, and

David S. Wood

, ESSA’s Chief Financial Officer, will also be participating in the one-on-one meetings.

Presentation Details

Presentation Date:               Thursday, March 17, 2022

Presentation Time:               2:40 p.m. ET

About ESSA Pharma Inc.


ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit

www.essapharma.com

and follow us on Twitter under

@ESSAPharma

.

A webcast of the presentation can be accessed in the Investors/Events & Presentations section of ESSA’s website at

www.essapharma.com

. Following the presentation, the webcast will be archived for 90 days.

View original content:

https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-oppenheimer-annual-healthcare-conference-301499623.html

SOURCE ESSA Pharma Inc